Predicate Research Report · generated 2026-08-23 · Print / save as PDF · Save to account
Senzime AB · Predicate Candidate Screening
3 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.
| K-number | Device | Applicant | Decided | Review days | Recalls (K-match) |
|---|---|---|---|---|---|
| K261098 | TetraGraph Neuromuscular Transmission Monitor (SEN 2015)Acce | Senzime AB | 2026-05-22 | 50 | 0 |
| K220530 | Tetragraph Neuromuscular Transmission Monitor | Senzime AB | 2022-08-17 | 174 | 0 |
| K190795 | Tetragraph Neuromuscular Transmission Monitor | Senzime AB | 2019-10-18 | 204 | 0 |
Methodology
Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.
Prepared with Atlas
Predicate research, review-time statistics and recall monitoring for 510(k) teams: atlasbyauro.com/fda